SOUTH SAN FRANCISCO, Calif. (AP) 鈥� SOUTH SAN FRANCISCO, Calif. (AP) 鈥� CytomX Therapeutics Inc. (CTMX) on Thursday reported a loss of $20.7 million in its second quarter.
The South San Francisco, California-based company said it had a loss of 9 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.
The biopharmaceutical company posted revenue of $1.4 million in the period.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CTMX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
